SMP is pleased to announce that over the last weeks, it had the honor of being involved in a further wide range of startup funding rounds in the venture capital sector.
SMP's Martin Schaper advised 1717 Life Science Ventures on the sale of its stake in drug developer PENTIXAPHARM to Eckert & Ziegler Strahlen- und Medizintechnik AG.
SMP advised early-stage investor and operational VC Project A on its investment in the AI platform Pactum.
SMP advised Flink on the establishment of an SE holding structure for its future German and European business as well as on the design of the governance and group structure.
SMP's Frederik Gärtner, Martin Schaper and Konstantin Häfner have advised early-stage investor and operational VC Project A on its investment in the learning platform Knowunity during its seed financing round.
SMP advised early-stage investor Amplifier on its investment in the Berlin-based startup Hive.
SMP again advised Munich-based insurance startup insureQ on its recent financing round led by early-stage investor Nauta Capital.
SMP advised medical cannabis producer and wholesaler DEMECAN on its new financing round. New investors as well as several existing shareholders participated in the investment in the upper single-digit million range.
A Team led by SMP partners Andreas Kortendick and Jens Kretzschmann has provided comprehensive tax advice to investment manager DTCP on the structuring of its investment in Open Dutch Fiber.
We use technologies such as cookies to provide you with the best possible service. This includes cookies that are used for the operation of the site and for anonymous statistical purposes.
If you click on "Accept", you agree to this. Under "More information" you can decide for yourself which cookies you would like to accept.
You can change your cookie settings at any time on the "Cookies" page or withdraw your consent with effect for the future.